Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q1 2023 · 10-Q
Revenue$8.78M$8.78M+164.7% vs Q1 2022 Net Income-$25.06M-$25.06MN/M vs Q1 2022 EPS Diluted-$6.75-$6.75N/M vs Q1 2022 Operating Income-$13,354,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
Free Cash Flowderived-$31,985,000N/M Margins · derivedOperating margin-152.1%+672.0 pt vs Q1 2022
Net margin-285.4%+563.8 pt vs Q1 2022
ended Mar 31, 2023 · filed May 9, 2023 · 39 d after period end